Associations of aspirin, statins and metformin with lung cancer risk and related mortality

Armin Frille; Adrien Costantini; Katherina B Sreter

doi:10.1183/20734735.0325-2020

Associations of aspirin, statins and metformin with lung cancer risk and related mortality

Breathe (Sheff). 2021 Jun;17(2):200325. doi: 10.1183/20734735.0325-2020.

Authors

Armin Frille¹, Adrien Costantini², Katherina B Sreter³

Affiliations

¹ Dept of Respiratory Medicine, University of Leipzig, Leipzig, Germany.
² Dept of Respiratory Diseases and Thoracic Oncology, APHP-Hôpital Ambroise Paré, Boulogne-Billancourt, France.
³ Dept of Clinical Immunology, Pulmonology and Rheumatology, University Hospital Centre "Sestre Milosrdnice", Zagreb, Croatia.

Abstract

Given the poor survival of lung cancer patients and the promising observations herein, future studies (RCTs) should further investigate both time- and dose-dependent effects of combination therapies across all categories of prevention of lung cancer. https://bit.ly/3hlYTtY.